pubmed-article:9563075 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9563075 | lifeskim:mentions | umls-concept:C0015677 | lld:lifeskim |
pubmed-article:9563075 | lifeskim:mentions | umls-concept:C0031327 | lld:lifeskim |
pubmed-article:9563075 | lifeskim:mentions | umls-concept:C0033487 | lld:lifeskim |
pubmed-article:9563075 | lifeskim:mentions | umls-concept:C0851347 | lld:lifeskim |
pubmed-article:9563075 | lifeskim:mentions | umls-concept:C0348016 | lld:lifeskim |
pubmed-article:9563075 | lifeskim:mentions | umls-concept:C0524527 | lld:lifeskim |
pubmed-article:9563075 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:9563075 | pubmed:dateCreated | 1998-7-29 | lld:pubmed |
pubmed-article:9563075 | pubmed:abstractText | The influence of different intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol was investigated using the effect on the EEG (11.5-30 Hz) as pharmacodynamic endpoint. | lld:pubmed |
pubmed-article:9563075 | pubmed:language | eng | lld:pubmed |
pubmed-article:9563075 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9563075 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9563075 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9563075 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9563075 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9563075 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9563075 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9563075 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9563075 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9563075 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9563075 | pubmed:month | Mar | lld:pubmed |
pubmed-article:9563075 | pubmed:issn | 0724-8741 | lld:pubmed |
pubmed-article:9563075 | pubmed:author | pubmed-author:LangeRR | lld:pubmed |
pubmed-article:9563075 | pubmed:author | pubmed-author:DanhofMM | lld:pubmed |
pubmed-article:9563075 | pubmed:author | pubmed-author:GilJ AJA | lld:pubmed |
pubmed-article:9563075 | pubmed:author | pubmed-author:LangemeijerM... | lld:pubmed |
pubmed-article:9563075 | pubmed:author | pubmed-author:Lie-A-HuenLL | lld:pubmed |
pubmed-article:9563075 | pubmed:author | pubmed-author:KuksP FPF | lld:pubmed |
pubmed-article:9563075 | pubmed:author | pubmed-author:LangemeijerH... | lld:pubmed |
pubmed-article:9563075 | pubmed:author | pubmed-author:KnibbeC ACA | lld:pubmed |
pubmed-article:9563075 | pubmed:author | pubmed-author:KosterV SVS | lld:pubmed |
pubmed-article:9563075 | pubmed:author | pubmed-author:TukkerE EEE | lld:pubmed |
pubmed-article:9563075 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9563075 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:9563075 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9563075 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9563075 | pubmed:pagination | 442-8 | lld:pubmed |
pubmed-article:9563075 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:9563075 | pubmed:meshHeading | pubmed-meshheading:9563075-... | lld:pubmed |
pubmed-article:9563075 | pubmed:meshHeading | pubmed-meshheading:9563075-... | lld:pubmed |
pubmed-article:9563075 | pubmed:meshHeading | pubmed-meshheading:9563075-... | lld:pubmed |
pubmed-article:9563075 | pubmed:meshHeading | pubmed-meshheading:9563075-... | lld:pubmed |
pubmed-article:9563075 | pubmed:meshHeading | pubmed-meshheading:9563075-... | lld:pubmed |
pubmed-article:9563075 | pubmed:meshHeading | pubmed-meshheading:9563075-... | lld:pubmed |
pubmed-article:9563075 | pubmed:meshHeading | pubmed-meshheading:9563075-... | lld:pubmed |
pubmed-article:9563075 | pubmed:meshHeading | pubmed-meshheading:9563075-... | lld:pubmed |
pubmed-article:9563075 | pubmed:meshHeading | pubmed-meshheading:9563075-... | lld:pubmed |
pubmed-article:9563075 | pubmed:meshHeading | pubmed-meshheading:9563075-... | lld:pubmed |
pubmed-article:9563075 | pubmed:meshHeading | pubmed-meshheading:9563075-... | lld:pubmed |
pubmed-article:9563075 | pubmed:meshHeading | pubmed-meshheading:9563075-... | lld:pubmed |
pubmed-article:9563075 | pubmed:meshHeading | pubmed-meshheading:9563075-... | lld:pubmed |
pubmed-article:9563075 | pubmed:meshHeading | pubmed-meshheading:9563075-... | lld:pubmed |
pubmed-article:9563075 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9563075 | pubmed:articleTitle | Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol. | lld:pubmed |
pubmed-article:9563075 | pubmed:affiliation | Division of Pharmacology, University of Leiden, Sylvius Laboratory, The Netherlands. | lld:pubmed |
pubmed-article:9563075 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9563075 | pubmed:publicationType | Comparative Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9563075 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9563075 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9563075 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9563075 | lld:pubmed |